Transplant recipients push back on CMS testing rule changes

CMS has revised rules for molecular diagnostic testing for organ transplant patients, limiting access and creating a barrier.

Related Keywords

United States , American , , American Society Of Transplant Surgeons , American Society Of Transplantation , Members Of Congress , United States Today , American Society , Transplant Surgeons , Medicare Administrative Contractors , Local Coverage Determination , Organ Transplant , Molecular Diagnostic Testing , Ms , Biopsy , Congress , Evidence ,